We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
After the completion of the all-stock merger of equals between Allkem and Livent Corporation, investors may be pondering buying shares of the newly formed Arcadium Lithium (ALTM - Free Report) . Unfortunately, Arcadium’s stock currently lands a Zacks Rank #5 (Strong Sell) and the Bear of the Day.
While a quick glance at Arcadium’s long-term outlook looks attractive on paper let’s see why investors may want to stay clear at the moment.
Taking a Closer Look Reveals Cause for Short-Term Concern
Arcadium began trading last Friday with the merger between Allkem and Livent creating a leading global lithium chemicals producer. The newly formed company says it is committed to safety and responsibly harnessing the power of lithium to improve people’s lives and accelerate the transition to clean energy.
According to Zacks estimates, the combined companies are expected to round out fiscal 2023 with annual earnings up 35% to $1.89 per share compared to $1.40 a share in 2022. However, FY24 EPS is projected to drop -23% to $1.46 a share.
While Arcadium’s bottom line may still look enticing with shares trading at $6 and just 4.4X forward earnings the trend of earnings estimate revisions shines a dimmer light. Over the last 60 days, FY23 earnings estimates have dipped -2% while FY24 EPS estimates have dropped -17%.
Image Source: Zacks Investment Research
Negative Q4 ESP
The Zacks Earnings ESP (Expected Surprise Prediction) also has Arcadium missing fourth quarter earnings expectations by -13% with the Zacks Consensus having Q4 EPS at $0.36 but the Most Accurate Estimate at $0.31 a share.
Arcadium is scheduled to report its Q4 results on Tuesday, February 13, and for now, the possibility of better-than-expected guidance looks slim as its Zacks Chemical-Specialty Industry is in the bottom 17% of over 250 Zacks industries. For Arcadium specifically, Lithium prices have been submerged in volatility over the last year and a sharp rebound in the commodity price may be necessary before investors get overly excited about its stock being cheap.
Image Source: Zacks Investment Research
Bottom Line
The "too-good-to-be-true" feeling about Arcadium’s stock is warranted at the moment and it would be no surprise if shares moved lower even at $6. Although Arcadium’s long-term prospects are still attractive its short-term price movement could be frustrating.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Bear of the Day: ARCADIUM LITHM (ALTM)
After the completion of the all-stock merger of equals between Allkem and Livent Corporation, investors may be pondering buying shares of the newly formed Arcadium Lithium (ALTM - Free Report) . Unfortunately, Arcadium’s stock currently lands a Zacks Rank #5 (Strong Sell) and the Bear of the Day.
While a quick glance at Arcadium’s long-term outlook looks attractive on paper let’s see why investors may want to stay clear at the moment.
Taking a Closer Look Reveals Cause for Short-Term Concern
Arcadium began trading last Friday with the merger between Allkem and Livent creating a leading global lithium chemicals producer. The newly formed company says it is committed to safety and responsibly harnessing the power of lithium to improve people’s lives and accelerate the transition to clean energy.
According to Zacks estimates, the combined companies are expected to round out fiscal 2023 with annual earnings up 35% to $1.89 per share compared to $1.40 a share in 2022. However, FY24 EPS is projected to drop -23% to $1.46 a share.
While Arcadium’s bottom line may still look enticing with shares trading at $6 and just 4.4X forward earnings the trend of earnings estimate revisions shines a dimmer light. Over the last 60 days, FY23 earnings estimates have dipped -2% while FY24 EPS estimates have dropped -17%.
Image Source: Zacks Investment Research
Negative Q4 ESP
The Zacks Earnings ESP (Expected Surprise Prediction) also has Arcadium missing fourth quarter earnings expectations by -13% with the Zacks Consensus having Q4 EPS at $0.36 but the Most Accurate Estimate at $0.31 a share.
Arcadium is scheduled to report its Q4 results on Tuesday, February 13, and for now, the possibility of better-than-expected guidance looks slim as its Zacks Chemical-Specialty Industry is in the bottom 17% of over 250 Zacks industries. For Arcadium specifically, Lithium prices have been submerged in volatility over the last year and a sharp rebound in the commodity price may be necessary before investors get overly excited about its stock being cheap.
Image Source: Zacks Investment Research
Bottom Line
The "too-good-to-be-true" feeling about Arcadium’s stock is warranted at the moment and it would be no surprise if shares moved lower even at $6. Although Arcadium’s long-term prospects are still attractive its short-term price movement could be frustrating.